Table 1.

Clinical and histopathological information for each patient used for gene expression profiling

Patient	Gender	T-stage	N status	Relapse	Dead of Bladder cancer	Time to relapse (months)	Follow up (months)
2211	Man	4a	Positive	No	No		24
1599	Woman	1	Positive	No	No		22
2114	Man	3b	Positive	Yes	Yes	9	61
2117	Man	3b	Positive	No	No		11
2130	Man	1	Positive	Yes	Yes	14	16
2163	Man	2	Positive	No	No		65
2180	Man	3	Positive	Yes	Yes	18	30
2207	Man	4a	Positive	Yes	Yes	9	22
2249	Woman	1	Positive	Yes	Yes	3	13
2237	Woman	2	Positive	No	No		31
1956	Man	1	Negative	No	No		66
1930	Man	1	Negative	No	No		61
1940	Woman	2	Negative	No	No		61
1743	Man	1	Negative	Yes	Yes	40	57
2036	Man	2	Negative	No	No		77
1874	Man	3b	Negative	No	No		63
1607	Woman	2	Negative	No	No		60
1956	Man	1	Negative	No	No		61